These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21627705)

  • 1. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study.
    Gilliam FR; Hayes DL; Boehmer JP; Day J; Heidenreich PA; Seth M; Jones PW; Stein KM; Saxon LA
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):1023-9. PubMed ID: 21627705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
    Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
    J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.
    Schwab JO; Bonnemeier H; Kleemann T; Brachmann J; Fischer S; Birkenhauer F; Eberhardt F
    Clin Res Cardiol; 2015 Dec; 104(12):1021-32. PubMed ID: 26002818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to avoid inappropriate therapy.
    Israel CW
    Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis.
    Kutyifa V; Daubert JP; Olshansky B; Huang DT; Zhang C; Ruwald AC; McNitt S; Zareba W; Moss AJ; Schuger C
    Heart Rhythm; 2015 Sep; 12(9):2030-7. PubMed ID: 26001510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial.
    Kolb C; Sturmer M; Babuty D; Sick P; Davy JM; Molon G; Schwab JO; Mantovani G; Wickliffe A; Lennerz C; Semmler V; Siot PH; Reif S
    Sci Rep; 2016 Feb; 6():21748. PubMed ID: 26892534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does change in device detected frequency of non-sustained or diverted episodes serve as a marker for inappropriate shock therapy? Analyses from the INTRINSIC RV and ALTITUDE-REDUCES Trials.
    Sullivan RM; Seth M; Berg K; Stolen KQ; Jones PW; Russo AM; Gilliam FR; Olshansky B
    Europace; 2014 May; 16(5):668-73. PubMed ID: 24489072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
    Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
    Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of inappropriate shocks in ICD recipients: a review of 10,000 tachycardia episodes.
    Anselme F; Mletzko R; Bowes R; Mabo P; Sadoul N; Schoels W; Seidl K; Schwab J; Iscolo N; Nitzsché R
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S128-33. PubMed ID: 17302688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the introduction of a standardised ICD programming protocol: real-world data from a single centre.
    Sunderland N; Kaura A; Li A; Kamdar R; Petzer E; Dhillon P; Murgatroyd F; Scott PA
    J Interv Card Electrophysiol; 2016 Sep; 46(3):335-43. PubMed ID: 27259568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing ICD programming for shock reduction.
    Schwab JO
    Fundam Clin Pharmacol; 2010 Oct; 24(5):653-9. PubMed ID: 20854304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.